Characterisation and aerosolisation of mannitol particles produced via confined liquid impinging jets

International Journal of Pharmaceutics

Volumn 367, Issue 1-2, 2009, Pages 51-57

  Tang, P ^a   Chan, H K ^a   Chiou, H ^a   Ogawa, K ^a   Jones, M D ^b   Adi, H ^a   Buckton, G ^b   Prud'homme, R K ^c   Raper, J A ^d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c Princeton University   (United States)

^d Architectural and Environmental Engineering   (United States)

Author keywords

Confined liquid impinging jet; Inhalation drug delivery; Inverse gas chromatography (IGC); Mannitol; Particle shape

Indexed keywords

MANNITOL; PEARLITOL; UNCLASSIFIED DRUG;

AEROSOL; AIRFLOW; ARTICLE; CRYSTALLIZATION; DRUG ANALYSIS; PARTICLE SIZE; PRIORITY JOURNAL; SPRAY DRYING;

ADMINISTRATION, INHALATION; AEROSOLS; CHROMATOGRAPHY, GAS; CRYSTALLIZATION; DRUG COMPOUNDING; MANNITOL; PARTICLE SIZE; POWDERS; SURFACE PROPERTIES; X-RAY DIFFRACTION;

EID: 58249107940     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.09.024     Document Type: Article

References (31)

1. Anderson S.D., Brannan J., Spring J., Spalding N., Rodwell L.T., Chan H.-K., Gonda I., Walsh A., and Clark A.R. A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am. J. Respir. Crit. Care 156 (1997) 758-765
2. Brannan J., Anderson S.D., Perry C.P., Freed-Martens R., Lassig A.R., and Charlton B. The safety and efficacy of inhaled dry powder mannitol as a bronchial provacation test for airway hyperresponsiveness: a phase 3 comparision study with hypertonic (4.5%) saline. Respir. Res. 6 (2005) 144
3. Burger A., Henck J.-O., Hetz S., Rollinger J.M., Weissnicht A.A., and Stottner H. Energy/temperature diagram and compression behavior of the polymorphs of d-mannitol. J. Pharm. Sci. 89 (2000) 457-468
4. Chan H.K., and Gonda I. Aerodynamic properties of elongated particles of cromoglycic acid. J. Aerosol Sci. 20 (1989) 157-168
5. Chan H.K., and Gonda I. Respirable form of crystals of cromoglycic acid. J. Pharm. Sci. 78 (1989) 176-180
6. Chan H.-K., and Gonda I. Physicochemical characterization of a new respirable form of nedocromil. J. Pharm. Sci. 84 (1995) 692-696
7. Chew N.Y.K., and Chan H.K. Influence of particle size, air flow, and inhaler device on the dispersion of mannitol powders as aerosols. Pharm. Res. 16 (1999) 1098-1103
8. Chew N.Y.K., Bagster D.F., and Chan H.K. Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders. Int. J. Pharm. 206 (2000) 75-83
9. Chew N.Y.K., and Chan H.-K. In vitro aerosol performance and dose uniformity between the Foradile Aeroliser and the Oxis Turbuhaler. J. Aerosol Med. 14 (2001) 495-501
10. Chew N.Y.K., and Chan H.K. Use of solid corrugated particles to enhance aerosol performance. Pharm. Res. 18 (2001) 1570-1577
11. Chew N.Y.K., and Chan H.K. Effect of powder polydispersity on aerosol generation. J Pharm. Pharm. Sci. 5 (2002) 162-168
12. Chan, H.K., 2007. In: Dalby, R.N., Byron, P.R., Peart, J., Suman, J. D. (Eds), The Role of Particle Morphology in Powder Inhalers. Respiratory Drug Delivery Europe, Paris. Davis Healthcare International Publishing, River Grove, IL, p. 187-196.
13. Chiou H., Chan H.-K., Prud'homme R.K., and Raper J.A. Evaluation on the use of confined liquid impinging jets for the synthesis of nanodrug particles. Drug Dev. Ind. Pharm. 34 (2008) 59-64
14. Clark A.R., and Hollingworth A.M. The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers-implications for in-vitro testing. J. Aerosol Med. 6 (1993) 99-110
15. Coates M.S., Chan H.-K., Fletcher D.F., and Raper J.A. Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 1. Grid structure and mouthpiece length. J. Pharm. Sci. 93 (2004) 2863-2876
16. Coates M.S., Chan H.-K., Fletcher D.F., and Raper J.A. The influence of air flow on the performance of a dry powder inhaler using computational and experimental analyses. Pharm. Res. 22 (2005) 1445-1453
17. Coates M.S., Chan H.-K., Fletcher D.F., and Raper J.A. The role of capsule on the performance of a dry powder inhaler using computational and experimental analyses. Pharm. Res. 22 (2005) 923-932
18. Coates M.S., Chan H.-K., Fletcher D.F., and Raper J.A. Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 2. Air inlet size. J. Pharm. Sci. 95 (2006) 1382-1392
19. Daviskas E., Anderson S.D., Brannan J.D., Chan H.-K., Eberl S., and Bautovich G. Inhalation of dry-powder mannitol increases mucociliary clearance. Eur. Respir. J. 10 (1997) 2449-2454
20. Daviskas E., Anderson S.D., Eberl S., Chan H.-K., and Bautovich G. Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis. Am. J. Respir. Crit. Care 159 (1999) 1843-1848
21. Daviskas E., Anderson S.D., Eberl S., Chan H.-K., and Young I.H. The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis. Chest 119 (2001) 414-421
22. Daviskas E., Anderson S.D., Gomes K., Briffa P., Cochrane B., Chan H.-K., and Bautovich G. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis-effect on lung function. Health status and sputum. Respirology 10 (2005) 46-56
23. Glover W., Chan H.-K., Eberl S., Daviskas E., and Anderson S. Lung deposition of mannitol powder aerosol in healthy subjects. J. Aerosol Med. 19 (2006) 522-532
24. Gonda I., and Abd El Khalik A.F. On the calculation of aerodynamic diameters of fibers. Aerosol Sci. Technol. 4 (1985) 233-238
25. Heng J.Y.Y., Thielmann F., and Williams D.R. The effects of milling on the surface properties of form I paracetamol crystals. Pharm. Res. 23 (2006) 1918-1927
26. Johnson B.K., and Prud'homme R.K. Chemical processing and micromixing in confined impinging jets. AIChE J. 49 (2003) 2264-2282
27. Johnson B.K., and Prud'homme R.K. Flash nanoprecipitation of organic actives and block copolymers using a confined impinging jets mixer. Aust. J. Chem. 56 (2003) 1021-1024
28. Kim A.I., Akers M.J., and Nail S.L. The physical state of mannitol after freeze-drying: effects of mannitol concentration, freezing rate, and a noncrystallizing cosolute. J. Pharm. Sci. 87 (1998) 931-935
29. Rasband, W.S., 1997-2006. ImageJ (http://rsb.info.nih.gov/ij/), U.S. National Institutes of Health, Bethesda, MD, USA.
30. Robinson M., Daviskas E., Eberl S., Baker J., Chan H.-K., Anderson S.D., and Bye P.T. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study. Eur. Respir. J. 14 (1999) 678-685
31. Schultz J., Lavielle L., and Martin C. The role of the interface on carbon fiber-epoxy composites. J. Adhes. 23 (1987) 45-60